Related Experiment Video
Updated: May 14, 2026

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
Published on: April 2, 2021
Nutrition, insulin-like growth factor-1 and retinopathy of prematurity
Anna-Lena Hård1, Lois E Smith2, Ann Hellström1
1Section of Pediatric Ophthalmology, The Queen Silvia Children's Hospital, The Sahlgrenska Academy at University of Gothenburg, S-416 85 Göteborg, Sweden.
Insights
Preventing retinopathy of prematurity (ROP) is crucial. Poor neonatal growth after preterm birth increases ROP risk, highlighting the need for better nutrition and growth strategies to protect infant vision.
Area of Science:
- Neonatal Medicine
- Ophthalmology
- Developmental Biology
Background:
- Retinopathy of prematurity (ROP) is a leading cause of infant blindness, characterized by abnormal retinal vascular development.
- Current treatments address late-stage ROP, emphasizing the need for preventative strategies.
- Poor overall growth in preterm infants is a significant risk factor for developing ROP.
Purpose of the Study:
- To review essential factors for neonatal growth.
- To explore strategies for improving growth and preventing ROP.
- To bridge findings from animal studies to human infant applications.
Main Methods:
- Literature review focusing on neonatal growth factors and ROP.
- Analysis of maternal-fetal interactions and their impact on development.
- Synthesis of evidence on nutrition, IGF-1, and omega-3 fatty acids in retinal vascularization.
Main Results:
- Impaired retinal vessel growth in neonates can lead to ROP.
- Loss of maternal-fetal exchange affects nutrient and factor delivery crucial for development.
- Animal studies demonstrate the importance of nutrition, IGF-1, and ω-3 fatty acids for retinal vascularization.
Conclusions:
- Optimizing neonatal growth is key to preventing ROP.
- Understanding and supplementing essential factors lost in preterm birth may prevent this blinding condition.
- Further research into nutritional and growth-promoting strategies can improve outcomes for preterm infants.
Abstract:
Retinopathy of prematurity is a potentially blinding disease starting with impaired retinal vessel growth in the neonatal period. Weeks to months later, peripheral retinal hypoxia induces pathologic neovascularization that may lead to retinal detachment and blindness. Current treatment strategies target late stage disease and it would be advantageous if retinopathy of prematurity could be prevented. Poor general growth after very preterm birth is a universal problem associated with increased risk of retinopathy. Loss of the maternal-fetal interaction results not only in loss of nutrients but also of other factors provided in utero. The importance of nutrition and factors such as insulin-like growth factor-1 and ω-3 long chain fatty acids for proper retinal vascularization has been defined in animal studies. Increasing evidence of the applicability of these findings to human infants is accumulating. This review focuses on factors essential for neonatal growth and possible strategies to improve growth and prevent retinopathy.
Related Concept Videos
Diabetic Retinopathy
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes III: Clinical Manifestations
Regulation of Angiogenesis and Blood Supply
Type II Diabetes II: Pathophysiology

